Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Chemours (CC) EBT (2016 - 2025)

Historic EBT for Chemours (CC) over the last 12 years, with Q3 2025 value amounting to $51.0 million.

  • Chemours' EBT rose 25937.5% to $51.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$214.0 million, marking a year-over-year decrease of 69444.44%. This contributed to the annual value of $106.0 million for FY2024, which is 11661.44% up from last year.
  • Chemours' EBT amounted to $51.0 million in Q3 2025, which was up 25937.5% from -$261.0 million recorded in Q2 2025.
  • In the past 5 years, Chemours' EBT ranged from a high of $302.0 million in Q4 2021 and a low of -$433.0 million during Q2 2023
  • Moreover, its 5-year median value for EBT was $51.0 million (2025), whereas its average is $52.3 million.
  • As far as peak fluctuations go, Chemours' EBT skyrocketed by 42500.0% in 2022, and later plummeted by 47826.09% in 2025.
  • Over the past 5 years, Chemours' EBT (Quarter) stood at $302.0 million in 2021, then plummeted by 122.85% to -$69.0 million in 2022, then decreased by 2.9% to -$71.0 million in 2023, then surged by 112.68% to $9.0 million in 2024, then surged by 466.67% to $51.0 million in 2025.
  • Its EBT was $51.0 million in Q3 2025, compared to -$261.0 million in Q2 2025 and -$13.0 million in Q1 2025.